Govender P - Search Results

1

Obesity and sarcoidosis: consequence or contributor?

Cozier YC, Govender P, Berman JS. Cozier YC, et al. Among authors: govender p. Curr Opin Pulm Med. 2018 Sep;24(5):487-494. doi: 10.1097/MCP.0000000000000503. Curr Opin Pulm Med. 2018. PMID: 29979212 Review.

2

Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.

Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, Govender P, Ruberg FL, Miller EJ. Ahmadian A, et al. Among authors: govender p. J Nucl Cardiol. 2014 Oct;21(5):925-39. doi: 10.1007/s12350-014-9901-9. Epub 2014 May 31. J Nucl Cardiol. 2014. PMID: 24879453

3

Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women's Health Study.

Cozier YC, Coogan PF, Govender P, Berman JS, Palmer JR, Rosenberg L. Cozier YC, et al. Among authors: govender p. Chest. 2015 Apr;147(4):1086-1093. doi: 10.1378/chest.14-1099. Chest. 2015. PMID: 25411869 Free PMC article.

4

The Diagnosis of Sarcoidosis.

Govender P, Berman JS. Govender P, et al. Clin Chest Med. 2015 Dec;36(4):585-602. doi: 10.1016/j.ccm.2015.08.003. Epub 2015 Oct 9. Clin Chest Med. 2015. PMID: 26593135 Review.

5

The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.

Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. Ahmadian A, et al. Among authors: govender p. J Nucl Cardiol. 2017 Apr;24(2):413-424. doi: 10.1007/s12350-016-0490-7. Epub 2016 Jul 25. J Nucl Cardiol. 2017. PMID: 27457527 Clinical Trial.

6

Treatment of Sarcoidosis.

Raghu G, Berman JS, Govender P. Raghu G, et al. Among authors: govender p. Am J Respir Crit Care Med. 2018 Mar 15;197(6):P9-P10. doi: 10.1164/rccm.1976P9. Am J Respir Crit Care Med. 2018. PMID: 29543101 Review. No abstract available.

7

Sarcoidosis: An Ill-afforded Disease.

Cozier YC, Govender P. Cozier YC, et al. Among authors: govender p. Am J Respir Crit Care Med. 2020 Apr 15;201(8):890-891. doi: 10.1164/rccm.202001-0047ED. Am J Respir Crit Care Med. 2020. PMID: 31978312 Free PMC article. No abstract available.

8

Sarcoidosis in a time of pandemic.

Govender P, Cozier YC. Govender P, et al. Eur Respir J. 2020 Sep 3;56(3):2002376. doi: 10.1183/13993003.02376-2020. Print 2020 Sep. Eur Respir J. 2020. PMID: 32883761 Free article. No abstract available.

9

Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension.

Abston E, Moll M, Hon S, Govender P, Berman J, Farber H. Abston E, et al. Among authors: govender p. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):184-191. doi: 10.36141/svdld.v37i2.9150. Epub 2020 Jun 30. Sarcoidosis Vasc Diffuse Lung Dis. 2020. PMID: 33093782 Free PMC article.

10

Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.

Abston E, Hon S, Lawrence R, Berman J, Govender P, Farber HW. Abston E, et al. Among authors: govender p. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):234-238. doi: 10.36141/svdld.v37i2.9343. Epub 2020 Jun 30. Sarcoidosis Vasc Diffuse Lung Dis. 2020. PMID: 33093789 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters